DNA and RNA Vaccines: Current Status, Quality Requirements and Specific Aspects of Preclinical Studies
This review focuses on DNA and RNA vaccines whose potential use was first considered at the end of the 20th century. However, not a single bacterial plasmid-based or mRNA vaccine has been used since that time in public healthcare for the prevention of infectious diseases. Nevertheless, vaccines cont...
Saved in:
Main Authors: | A. A. Goryaev, M. V. Savkina, Yu. I. Obukhov, V. A. Merkulov, Yu. V. Olefir |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2019-06-01
|
Series: | Биопрепараты: Профилактика, диагностика, лечение |
Subjects: | |
Online Access: | https://www.biopreparations.ru/jour/article/view/218 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity of DNA, mRNA and Subunit Vaccines Against Beak and Feather Disease Virus
by: Buyani Ndlovu, et al.
Published: (2025-07-01) -
Circular RNA vaccines: Pioneering the next-gen cancer immunotherapy
by: Uddalak Das, et al.
Published: (2025-07-01) -
The Current State of Vaccine Development for Specific Prophylactics of Arenaviral Hemorrhagic Fevers
by: T. E. Sizikova, et al.
Published: (2018-07-01) -
Innovation in mRNA Vaccines and RNAi via Protein Nanocages
by: Sohrab Ahmadivand
Published: (2025-06-01) -
A novel combined quadrivalent self-amplifying mRNA-LNP vaccine provokes protective immunity against acute and chronic toxoplasmosis in mice
by: Qinli Wu, et al.
Published: (2025-06-01)